The efficacy of chemically-stabilized chlorite-matrix (TCDO *) in the management of late postradiation cystitis

Journal of the Medical Association of Thailand

Volumn 82, Issue 8, 1999, Pages 797-802

  Srisupundit, Somkeart ^a   Sangruchi, Supatra ^b   Chingskol, Kiatichai ^a   Kraiphibul, Puangtong ^a   Linasmita, Vasant ^a   Veerasarn, Vutisiri ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Radiation Cystitis; TCDO

Indexed keywords

CHLORINE; OXIDE; RADIOPROTECTIVE AGENT; TETRACHLORODECAOXIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CYSTITIS; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; RADIATION INJURY; TREATMENT OUTCOME; UTERINE CERVIX TUMOR;

ADULT; AGED; CHLORINE; CYSTITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; OXIDES; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0033176098     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Vatanasapt V, Martin N, Sriplung H, et al. Cancer in Thailand 1988-1001. IARC Technical Report No. 16 Lyon 1993: 68-9.
2. Cox JD, Steig J, Thomas P. Toxicity criteria of the Radiation Therapy Oncology Group. (RTOG) and The European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
3. Bosch A, Frias Z. Complication after radiation therapy for cervical carcinoma. Acta Radiol Ther Phys Biol 1977;16:53-62.
4. Ivankovic S, Kempf R. Regenerative effect of Tetrachlorodecaoxide in BD IX rats after total body radiation. Radiat Res 1988;115:115-23.
5. Uttaravichien T. A prospective study to evaluate TCDO in the treatment of complicated postradiation cystitis Abstract. Int. Symp on Tissue Repair, Pattaya, Thailand Dec 6-8 (1990) in : Highlights. International Symposium on Tissue Repair, 23-25 (1990).
6. Kraiphibul P, Srisupundit S, Pairachavet V. Results of treatment in stage IIB squamous cell carcinoma of the uterine cervix: Comparison between two and one intracavitary insertion. Gynecologic Oncology 1992;45:160-3.
7. Rubin SC, Markman M, Nori D. Management of late effects, chapter 24, in: Hoskins, WJ, Perez, CA. Young, RC (eds.), Principles and Practice of Gynecologic Oncology, 2nd Edition. Philadelphia. Lippincott. Raven 1996:630-6.
8. deVries CR, Freiha FS. Haemorrhagic cystitis: A Review. J Urol 1990;143:1-9.
9. McGrath M, Gascon R, Kahn J, et al. Blood macrophage TNF-α expression, elevated in AIDS dementia is downregulated in vitro by WF10 exposure. In: Keystone Symposia on Molecular and Cellular Biology. Park City, Utah (1998).
10. McGrath M, Benike C, Kühne FW, Engleman E. Effect of WF10 (TCDO) on antigen presentation. In. Third International Conference on New Trends in Clinical and Experimental Immunosuppression. Geneva, Switzerland (1998);4200-4.
11. Dühme E. Strahlenbehandlung fortgeschrittener maligner Tumore unter dem Einfluß des Sauerstoffträgers Tetrachlordecaoxid (TCDO). (Radiation therapy of advanced malignant tumors under the influence of the oxygen-carrier tetrachlorodecaoygen TCDO) in : Elstner EF, Bors W, Wilmanns W. Reaktive Sauerstoffspezies in der Medizin, Springer Verlag, Berlin, Heidelberg, New York, London, Paris, Tokyo, (1986);238-46.
12. Kühne HH, Bressel M, Heitz M, Küppers F, Loch T, Stöckle M. Langzeitheilung eines ossär metastasierenden Prostatakarzinoms. Akt Urol 1998; 29:261-3.
13. Vikua S, Suchai S. TCDO in the treatment of acute radiation cystitis and proctitis. Abstract : Int. Symp. on Tissue Repair, Pattaya, Thailand, Dec. 6-8 (1990) in : Highlights - International Symposium on Tissue Repair, (1990);25-6.